Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

4.08
Delayed Data
As of 3:59pm ET
 -0.15 / -3.55%
Today’s Change
3.03
Today|||52-Week Range
10.21
-19.51%
Year-to-Date
No recent news for MabVax Therapeutics Holdings Inc.

Today’s Trading

Previous close4.23
Today’s open4.07
Day’s range4.07 - 4.25
Volume81,980
Average volume (3 months)66,176
Market cap$22.7M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+80.86%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)+303.29%
P/E ratio11.0
Price/Sales10.73
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
OPXAOpexa Therapeutics I...0.000.00%
CYCCCyclacel Pharmaceuti...+0.24+4.17%
WINTWindtree Therapeutic...+0.07+2.71%
PVCTProvectus Biopharmac...+0.00+2.77%
Data as of 4:01pm ET, 09/28/2016

Financials

Next reporting dateNovember 16, 2016
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$1.3M
Annual profit (last year)-$18.1M
Net profit margin-1,428.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
Chief Financial Officer
Gregory P. Hanson
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs